These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8421432)

  • 21. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
    Pruett SB; Han YC; Fuchs BA
    J Pharmacol Exp Ther; 1992 Sep; 262(3):923-8. PubMed ID: 1527733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenectomy modifies hyperactive states of the dopaminergic system induced by morphine in C57BL/6J-bg(J)/bg(J) (beige-J) mice.
    Funada M; Mori T; Maeda J; Tsuda Y; Komiya S; Shimizu N; Kamei J; Suzuki T
    Eur J Pharmacol; 2014 Nov; 742():89-93. PubMed ID: 25179571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
    Levier DG; Brown RD; McCay JA; Fuchs BA; Harris LS; Munson AE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):357-63. PubMed ID: 8229762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.
    Roy S; Guo X; Kelschenbach J; Liu Y; Loh HH
    J Neurosci; 2005 Mar; 25(12):3229-33. PubMed ID: 15788780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility.
    Bayer BM; Gastonguay MR; Hernandez MC
    Immunopharmacology; 1992; 23(2):117-24. PubMed ID: 1601640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse strain differences in immunosuppression by opioids in vitro.
    Eisenstein TK; Meissler JJ; Rogers TJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1484-9. PubMed ID: 8531119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
    Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
    Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro.
    Gordon J; Murgita RA; Tomasi TB
    J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice.
    Stevenson GW; Bilsky EJ; Negus SS
    J Pain; 2006 Jun; 7(6):408-16. PubMed ID: 16750797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
    Lysle DT; Coussons ME; Watts VJ; Bennett EH; Dykstra LA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1071-8. PubMed ID: 7685383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
    Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
    Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy.
    Sirohi S; Kumar P; Yoburn BC
    J Pharmacol Exp Ther; 2007 Nov; 323(2):701-7. PubMed ID: 17698975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation, storage pool deficiency, and protein phosphorylation in mice with Chediak-Higashi syndrome.
    Pratt HL; Carroll RC; Jones JB; Lothrop CD
    Am J Vet Res; 1991 Jun; 52(6):945-50. PubMed ID: 1652907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and morphological characterization of primary kidney cell cultures from beige mutant mice.
    Lyerla TA; Gross SK; Shea TB; Daniel PF; McCluer RH
    Cell Tissue Res; 1987 Dec; 250(3):627-32. PubMed ID: 3690638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):81-8. PubMed ID: 8474033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
    Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
    Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages.
    Rojavin M; Szabo I; Bussiere JL; Rogers TJ; Adler MW; Eisenstein TK
    Life Sci; 1993; 53(12):997-1006. PubMed ID: 8361330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.